Correlation between Ischaemia-modified Albumin and Intermediate-density Lipoprotein in Haemodialysis Patients with End-stage Renal Disease

Author： Kotani K Kimura S Kinugasa E Ogata H Caccavello R Taniguchi N Gugliucci A

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.4, 2011-07, pp. : 1541-1545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R. Scott Lesley J. Cvetković Risto S. Plosker Greg L.

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

Intravenous N -Acetylcysteine during Haemodialysis Reduces the Plasma Concentration of Homocysteine in Patients with End-Stage Renal Disease

By Thaha Mochammad

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 195-202

Adis International

Access to resources Recommend Favorite

High-risk End-stage Renal Disease Patients Converted from Conventional to Short Daily Haemodialysis

By He Q Chen J Zhang P Xie W Jiang H Yuan J

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 682-688

Field House Publishing

Access to resources Recommend Favorite

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K Zussman B Miller AK Freed MI

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

Epidemiology of end-stage renal disease

By Roderick Paul

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 200-204

Royal College Of Physicians

Access to resources Recommend Favorite